Atrial Fibrillation, Primary Aldosteronism
Conditions
Keywords
Atrial Fibrillation, Primary Aldosteronism
Brief summary
This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.
Interventions
Screening for primary aldosteronism will be performed with measurement of aldosterone-to-renin ratio after 2 hours of bed rest. Renin measurement will be performed by estimating plasma renin activity. The screening test will be considered positive when the ratio is \>30, accompanied by elevated aldosterone values (\>15 ng/ml). Patients with a positive result will undergo further confirmatory testing with intravenous sodium test (administration 2 liters of normal saline N/S 0.9%, over a period of 4 hours, while the patient is supine. Considered positive if aldosterone levels are \>5mg/dl at the end of the test). Alternative confirmatory methods are captopril test (Administration of 50 mg of captopril. Considered positive when aldosterone levels are \>8.5 mg/dl 2 hours after the intake) or hydrocortisone test (Administration of 0.1mg of hydrocortisone 4 times a day for a period of 4 days. Considered positive if elevated aldosterone levels (\>6ng/dl) are found at the end of the test).
Sponsors
Study design
Eligibility
Inclusion criteria
* Established diagnosis of atrial fibrillation with a standard surface ECG tracing of at least 30 seconds (either paroxysmal or persistent or permanent).
Exclusion criteria
* Diagnosis of primary aldosteronism * Diagnosis of heart failure, treated with mineralocorticoid receptor antagonists * Inability to be subjected to any confirmatory tests for primary aldosteronism * Acute vascular event (acute coronary syndrome, stroke, acute peripheral vascular event) within last 6 months * Renal replacement therapy * Incompetence of unwillingness to provide written informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of primary aldosteronism in patients with atrial fibrillation | Baseline | Percentage of patients with positive screening and confirmatory test for primary aldosteronism |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Association of marker of arterial stiffness with presence of primary aldosteronism in patients with atrial fibrillation | Baseline | Pulse wave velocity |
| Association of echocardiographic indices with presence of primary aldosteronism in patients with atrial fibrillation. | Baseline | Left ventricular global longitudinal strain (GLS) measured by transthoracic echocardiography |
Countries
Greece